These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 20638324)
1. Design of next-generation protein therapeutics. Caravella J; Lugovskoy A Curr Opin Chem Biol; 2010 Aug; 14(4):520-8. PubMed ID: 20638324 [TBL] [Abstract][Full Text] [Related]
2. Engineered protein scaffolds as next-generation antibody therapeutics. Gebauer M; Skerra A Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012 [TBL] [Abstract][Full Text] [Related]
3. Molecular engineering and design of therapeutic antibodies. Presta LG Curr Opin Immunol; 2008 Aug; 20(4):460-70. PubMed ID: 18656541 [TBL] [Abstract][Full Text] [Related]
4. Creating the next generation of protein therapeutics through rational drug design. Szymkowski DE Curr Opin Drug Discov Devel; 2005 Sep; 8(5):590-600. PubMed ID: 16159021 [TBL] [Abstract][Full Text] [Related]
5. Introduction to current and future protein therapeutics: a protein engineering perspective. Carter PJ Exp Cell Res; 2011 May; 317(9):1261-9. PubMed ID: 21371474 [TBL] [Abstract][Full Text] [Related]
6. Antibody engineering and modification technologies. Filpula D Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589 [TBL] [Abstract][Full Text] [Related]
7. Antibody therapeutics, antibody engineering, and the merits of protein stability. Demarest SJ; Glaser SM Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019 [TBL] [Abstract][Full Text] [Related]
8. Leveraging SBDD in protein therapeutic development: antibody engineering. Gilliland GL; Luo J; Vafa O; Almagro JC Methods Mol Biol; 2012; 841():321-49. PubMed ID: 22222459 [TBL] [Abstract][Full Text] [Related]